Kirby Institute

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: Private

Established: 1986-01-01

Employees: 101

Market Cap: -

Website: https://kirby.unsw.edu.au

Clinical Trials

The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar

Phase 4

Completed

Conditions: Helicobacter Pylori Infection

Interventions: Drug: Clarithromycin 500mg
Drug: Amoxicillin 500mg
Drug: Tinidazole 500mg
Drug: Rabeprazole 20mg

First Posted Date: 2019-10-18

Last Posted Date: 2019-10-18

Lead Sponsor: Kirby Institute

Target Recruit Count: 313

Registration Number: NCT04132479

Locations: 🇲🇲
Insein General Hospital, Yangon, Myanmar

Simplified Monitoring Myanmar SM2 Study

Not Applicable

Completed

Conditions: Liver Inflammation
Hepatitis C
HIV Infections
Liver Cirrhoses

Interventions: Device: HCV point of care machine

First Posted Date: 2019-10-03

Last Posted Date: 2021-02-21

Lead Sponsor: Kirby Institute

Target Recruit Count: 200

Registration Number: NCT04113629

Locations: 🇦🇺
The Kirby Institute, University of New South Wales Australia, Sydney, New South Wales, Australia

Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs

Not Applicable

Recruiting

Conditions: Hepatitis C, Chronic
Hepatitis C

Interventions: Diagnostic Test: Xpert HCV Viral Load Fingerstick
Diagnostic Test: Aptima HCV Quant DX Assay

First Posted Date: 2019-07-10

Last Posted Date: 2024-03-06

Lead Sponsor: Kirby Institute

Target Recruit Count: 2700

Registration Number: NCT04014179

Locations: 🇦🇺
Coffs Harbour Primary NSP, Coffs Harbour, New South Wales, Australia
🇦🇺
Liverpool Southwest NSP, Liverpool, New South Wales, Australia
🇦🇺
UC Adelaide, Adelaide, South Australia, Australia

and more 16 locations

Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage in People Who Inject Drugs

Not Applicable

Recruiting

Conditions: Hepatitis C
Liver Cirrhoses
Liver Inflammation

Interventions: Drug: Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet
Drug: Sofosbuvir 400 MG + Glecaprevir/Pibrentasvir 100 MG-40 MG Oral Tablet

First Posted Date: 2019-06-10

Last Posted Date: 2024-03-06

Lead Sponsor: Kirby Institute

Target Recruit Count: 60

Registration Number: NCT03981211

Locations: 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺
The Alfred Hospital, Melbourne, Victoria, Australia
🇦🇺
St Vincent's Hospital, Melbourne, Victoria, Australia

and more 4 locations

Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir

Phase 4

Recruiting

Conditions: Hepatitis C

Interventions: Drug: Sofosbuvir 400mg [Sovaldi]
Drug: Glecaprevir/pibrentasvir (300mg/120mg)

First Posted Date: 2019-02-27

Last Posted Date: 2024-03-06

Lead Sponsor: Kirby Institute

Target Recruit Count: 30

Registration Number: NCT03855917

Locations: 🇦🇺
Blacktown Mt Druitt Hospital, Sydney, New South Wales, Australia
🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺
St Vincent's Hospital, Darlinghurst, New South Wales, Australia

Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination

Conditions: Hepatitis C
Hepatitis
Liver Diseases
Hepatitis, Viral, Human
RNA Virus Infections
Digestive System Diseases

Interventions: Drug: glecaprevir/pibrentasvir
Device: Fingerstick GeneXpert HCV RNA quantitative assay
Drug: sofosbuvir/velpatesvir

First Posted Date: 2018-12-17

Last Posted Date: 2022-04-14

Lead Sponsor: Kirby Institute

Target Recruit Count: 600

Registration Number: NCT03776760

Locations: 🇦🇺
Jullums Lismore Aboriginal Medical Service, Lismore, New South Wales, Australia
🇦🇺
Walhallow Aboriginal Corporation, Quirindi, New South Wales, Australia
🇦🇺
Pangula Mannamurna Aboriginal Corporation, Mount Gambier, South Australia, Australia

and more 1 locations

Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting

Completed

Conditions: Hepatitis C, Chronic

First Posted Date: 2018-11-14

Last Posted Date: 2022-04-14

Lead Sponsor: Kirby Institute

Target Recruit Count: 202

Registration Number: NCT03740906

Locations: 🇦🇺
NSW Correctional Centres, Sydney, New South Wales, Australia

Impact of the Daily Doxycycline Pre-exposure Prophylaxis (PrEP) on the Incidence of Syphilis, Gonorrhoea and Chlamydia

Active, not recruiting

Conditions: STIs Prevention

First Posted Date: 2018-10-17

Last Posted Date: 2023-10-05

Lead Sponsor: Kirby Institute

Target Recruit Count: 100

Registration Number: NCT03709459

Locations: 🇦🇺
Royal Prince Alfred Hospital Sexual Health Medicine, Camperdown, New South Wales, Australia
🇦🇺
Kirketon Road Centre, Sydney, New South Wales, Australia
🇦🇺
Melbourne Sexual Health Centre, Melbourne, Victoria, Australia

and more 1 locations

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings

Not Applicable

Recruiting

Conditions: Hepatitis C

Interventions: Procedure: Campaign days

First Posted Date: 2018-09-26

Last Posted Date: 2024-03-06

Lead Sponsor: Kirby Institute

Target Recruit Count: 6000

Registration Number: NCT03685045

Locations: 🇦🇺
Lawrence Avenue Methadone Program (LAMP), Nowra, New South Wales, Australia
🇦🇺
WSLHD Mount Druitt Drug Health OST Clinic, Mount Druitt, New South Wales, Australia
🇦🇺
NSLHD Brookvale Community Health Centre, Brookvale, New South Wales, Australia

and more 26 locations

Body Composition Sub-study of the D2EFT Trial

Phase 4

Active, not recruiting

Conditions: HIV Infections

Interventions: Drug: Darunavir (DRV) 800 milligram (MG) Oral Tablet
Drug: Dolutegravir 50 MG Oral Tablet
Drug: TDF 300 MG Oral Tablet
Drug: Ritonavir 100 MG Oral Tablet
Drug: N(t)RTIs
Drug: 3TC 300 MG Oral Tablet
Drug: FTC 200 MG Oral Cap

First Posted Date: 2018-09-18

Last Posted Date: 2023-07-25

Lead Sponsor: Kirby Institute

Target Recruit Count: 155

Registration Number: NCT03675815

Locations: 🇿🇦
Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto, Johannesburg, South Africa
🇿🇦
Clinical HIV Research Unit, Helen Joseph Hospital, Westdene, Johannesburg, South Africa
🇿🇦
Desmond Tutu HIV Foundation, Cape Town, South Africa

and more 4 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy